Article Information
PubMed
Published By
History
- Received December 19, 2013
- Revision received June 7, 2014
- Accepted June 10, 2014
- First published July 9, 2014.
- Version of record published July 9, 2014.
Copyright & Usage
Copyright © 2014 the authors 0270-6474/14/349441-14$15.00/0
Author Information
Author contributions
Author contributions: D.G., E.V., B.S., E.R., K.U., S.N., P. Seubert, R.B., D.S., and E.M. designed research; E.V., B.S., E.R., M.M., A.A., C.P., P. Sacayon, R.B., and E.M. performed research; E.M. contributed unpublished reagents/analytic tools; D.G., E.V., B.S., E.R., K.U., S.N., P. Sacayon, W.Z., P. Seubert, R.B., and E.M. analyzed data; D.G., E.V., S.N., W.Z., P. Seubert, D.S., and E.M. wrote the paper.
Disclosures
- Received December 19, 2013.
- Revision received June 7, 2014.
- Accepted June 10, 2014.
This work was supported by the National Institutes of Health (Grants AG11385, AG18840, AG022074, and NS044233) and Prothena Biosciences.
D.G., P.S., W.Z., P.S., R.B., and D.S. are employees of Prothena, the company that develops the antibodies described in the manuscript. The remaining authors declare no competing financial interests.
- Correspondence should be addressed to Eliezer Masliah, M.D. University of California–San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0624. emasliah{at}ucsd.edu
